Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis : Review and meta-analysis.

Rezar R, Jirak P, Lichtenauer M, Jung C, Lauten A, Hoppe UC, Wernly B.

Wien Klin Wochenschr. 2020 Feb 10. doi: 10.1007/s00508-020-01614-z. [Epub ahead of print] Review.

PMID:
32040621
2.

Interventional emergency treatment of aortic valve stenosis. All along the watchtower.

Wernly B, Jung C.

Minerva Cardioangiol. 2020 Jan 24. doi: 10.23736/S0026-4725.19.05121-1. [Epub ahead of print] No abstract available.

PMID:
31992022
3.

Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction.

Wernly B, Paar V, Aigner A, Pilz PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B, Wimmer M, Kraus T, Motloch LJ, Hackl M, Hoppe UC, Kiss A, Lichtenauer M.

Cells. 2020 Jan 25;9(2). pii: E295. doi: 10.3390/cells9020295.

4.

Impella®: an updated meta-analysis of available data and future outlook on applications in cardiogenic shock.

Wernly B, Lauten A, Thiele H, Jung C.

Wien Klin Wochenschr. 2020 Jan 16. doi: 10.1007/s00508-019-01600-0. [Epub ahead of print] No abstract available.

PMID:
31950250
5.

Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury.

Wernly B, Fuernau G, Masyuk M, Muessig JM, Pfeiler S, Bruno RR, Desch S, Muench P, Lichtenauer M, Kelm M, Adams V, Thiele H, Eitel I, Jung C.

Sci Rep. 2019 Dec 4;9(1):18367. doi: 10.1038/s41598-019-54937-x.

6.

Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more.

Wernly B, Bhatt DL, Polzin A, Jung C.

J Thromb Thrombolysis. 2020 Feb;49(2):321-324. doi: 10.1007/s11239-019-02007-4.

PMID:
31797240
7.

Admission body temperature in critical ill patients as an independent risk predictor for overall outcome.

Erkens R, Wernly B, Masyuk M, Muessig J, Franz M, Schulze PC, Lichtenauer M, Kelm M, Jung C.

Med Princ Pract. 2019 Dec 2. doi: 10.1159/000505126. [Epub ahead of print]

8.

The role of arginase in the microcirculation in cardiovascular disease1.

Wernly B, Pernow J, Kelm M, Jung C.

Clin Hemorheol Microcirc. 2019 Nov 14. doi: 10.3233/CH-199237. [Epub ahead of print]

PMID:
31743994
9.

Hepatitis C virus (HCV) infection and cardiovascular disease: Hepatologists and cardiologists need to talk!

Wernly B, Wernly S, Niederseer D, Datz C.

Eur J Intern Med. 2020 Jan;71:87-88. doi: 10.1016/j.ejim.2019.10.015. Epub 2019 Nov 8. No abstract available.

PMID:
31708363
10.
11.

Trapping endothelin-1 to hunt down cardiovascular disease?

Wernly B, Jung C.

Drug Discov Today. 2019 Nov;24(11):2108-2110. doi: 10.1016/j.drudis.2019.10.007. Epub 2019 Oct 22. No abstract available.

PMID:
31654816
12.

Systematic Review and Meta-Analysis of Interventional Emergency Treatment of Decompensated Severe Aortic Stenosis.

Wernly B, Jirak P, Lichtenauer M, Veulemans V, Zeus T, Piayda K, Hoppe UC, Lauten A, Frerker C, Jung C.

J Invasive Cardiol. 2020 Jan;32(1):30-36. Epub 2019 Oct 15.

13.

Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation.

Wernly B, Frutos-Vivar F, Peñuelas O, Raymondos K, Muriel A, Du B, Thille AW, Ríos F, González M, Del-Sorbo L, Del Carmen Marín M, Pinheiro BV, Soares MA, Nin N, Maggiore SM, Bersten A, Kelm M, Amin P, Cakar N, Lichtenauer M, Suh GY, Abroug F, Jibaja M, Matamis D, Zeggwagh AA, Sutherasan Y, Anzueto A, Esteban A, Jung C.

Eur J Intern Med. 2019 Dec;70:18-23. doi: 10.1016/j.ejim.2019.09.002. Epub 2019 Oct 9.

PMID:
31606309
14.

Reply to the Letter to the Editor "Hypoglycemia and Mortality in Critically Ill Patients with Type 2 Diabetes".

Wernly B, Jung C.

Med Princ Pract. 2020;29(1):100. doi: 10.1159/000503242. Epub 2019 Oct 7. No abstract available.

15.
16.

Venous blood lactate concentrations in patients with shock: Interesting but not really helpful.

Wernly B, Bakker J, Jung C.

J Crit Care. 2019 Aug 10. pii: S0883-9441(19)30778-6. doi: 10.1016/j.jcrc.2019.08.007. [Epub ahead of print] No abstract available.

PMID:
31421917
17.

Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).

Mirna M, Rohm I, Jirak P, Wernly B, Bäz L, Paar V, Kretzschmar D, Hoppe UC, Schulze PC, Lichtenauer M, Jung C, Franz M.

Heart Lung Circ. 2019 Apr 1. pii: S1443-9506(19)30293-8. doi: 10.1016/j.hlc.2019.03.004. [Epub ahead of print]

PMID:
31327702
18.

Correction to: Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

Wernly B, Lichtenauer M, Erlinge D, Jung C.

Clin Res Cardiol. 2020 Jan;109(1):131. doi: 10.1007/s00392-019-01510-1.

PMID:
31278522
19.

The hospital frailty risk score is of limited value in intensive care unit patients.

Bruno RR, Wernly B, Flaatten H, Schölzel F, Kelm M, Jung C.

Crit Care. 2019 Jul 2;23(1):239. doi: 10.1186/s13054-019-2520-8. No abstract available.

20.

New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction.

Dalos D, Spinka G, Schneider M, Wernly B, Paar V, Hoppe U, Litschauer B, Strametz-Juranek J, Sponder M.

J Clin Med. 2019 Jun 27;8(7). pii: E924. doi: 10.3390/jcm8070924.

Supplemental Content

Loading ...
Support Center